Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2007
08/29/2007EP1824826A1 Aryl sulfonic pyridoxines as antiplatelet agents
08/29/2007EP1824825A1 Substituted pyridoxines as anti-platelet agents
08/29/2007EP1824481A1 Use of ribose-cysteine to treat hypoxia by enhancing delivery of glutathione and atp levels in cells
08/29/2007EP1824471A2 Modulation of nitric oxide synthases by betaines
08/29/2007EP1824465A2 Vulnerable plaque treatment
08/29/2007EP1824417A2 Materials and methods for treating and managing plaque disease
08/29/2007EP1725538B1 Pyridazinone ureas as antagonists of a4 integrins
08/29/2007EP1644385B1 Silicon compounds and their use
08/29/2007EP1562938B1 Heteroaryl-pyrimidine derivatives as jak inhibitors
08/29/2007EP1562629A4 Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2
08/29/2007EP1414961B1 Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression
08/29/2007EP1351934B1 Naphthalene derivatives which bind to the ep4 receptor
08/29/2007EP1333840B9 M. tuberculosis chaperonin 60.1 and uses thereof
08/29/2007EP1306083A4 Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion
08/29/2007EP1268431B1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
08/29/2007EP1165781B1 Protease resistant flint analogs
08/29/2007EP1140078B1 Benzimidazole vascular damaging agents
08/29/2007EP1096932B1 Antihypertensive combination of valsartan and calcium channel blocker
08/29/2007EP1054963B1 Sequences of an ih ionic channel and the use thereof
08/29/2007CN101027072A Herbal pharmaceutical compositions for prophylaxis and/or treatment of cardiovascular diseases and the method of preparing the same
08/29/2007CN101027068A Anti-angiogenic compositions containing beeswax
08/29/2007CN101025419A Method for testing effect of angiogenesis inhibitor via integrin expression inhibition
08/29/2007CN101024643A Imidazo-5-carboxylic-acid derivatives, its preparing method and use
08/29/2007CN101024628A Aza-flavones, its preparing method and use
08/29/2007CN101024627A Nitrogen-containing aromatic derivatives
08/29/2007CN101024086A Composition formed from chitosan and its derivatives and low-molecular heparin and pneparation and preparing method
08/29/2007CN101024082A Compounded medicine for wholely preventing and treating cardio-cerebral blood vessel diseases and use thereof
08/29/2007CN101024073A Use of humanbody kinino genase in preparing medicine for treating and preventing hypertension and cerebral infraction
08/29/2007CN101024048A Medicine for treating heart disease
08/29/2007CN101024043A Thrombus diminishing blood-pressure reducing preparation
08/29/2007CN101024039A Large-size oral dropping pills for clearing heat and Yin-tonifying and promoting blood circulation to remove stasis and preparing method
08/29/2007CN101024038A Medicine composition with fat-clearing, blood-pressure-reducing functions
08/29/2007CN101024032A Medicine made from onion and semen cassiae and preparing method
08/29/2007CN101024019A Gouzhi hemolysis soup
08/29/2007CN101024009A Compounded zhidi total extract and its preparation and use
08/29/2007CN101024002A Oral Chinese medicine composition for treating hypertension
08/29/2007CN101023983A Medicine composition and use
08/29/2007CN101023978A Zhiloukang medicine for treating hemorrhoids and fistula
08/29/2007CN101023975A Composition containing effective parts of astragalus root and Acanthopanx senticosusharm and its use thereof
08/29/2007CN101023969A Hippophate flavone powder capsule and its preparing method
08/29/2007CN101023964A Method for preparing brain tissue injure
08/29/2007CN101023958A Buccal tablet of Asraguluspolysacharin
08/29/2007CN101023956A Oral puerarin phosphate composition capsule and preparing method
08/29/2007CN101023951A Slow-released preparation containing hydrochlorothiazide and clonidine hydrochloride and its preparing method
08/29/2007CN101023946A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
08/29/2007CN101023945A Use of non-periphery substituted phthalocyaniu metal complex
08/29/2007CN101023943A Myricetin dispersion tablets for treating cardio-cerebral blood vessel diseases
08/29/2007CN101023942A Use of dihydro myricotin element for treating cardiac blood diseases
08/29/2007CN101023938A Atenolol frozen dry injecta and preparing method
08/29/2007CN101023936A A medicine for preventing ischemic disease in a diabetic patient
08/29/2007CN101023893A Endoluminal device for treating disease of aneurysm and combination of drugs
08/29/2007CN101023768A Hawthorn blood-pressure-reducing tea
08/29/2007CN101023767A Bamboo charcoal tea-cube
08/29/2007CN100334109C GLP-1 analogues
08/29/2007CN100334076C Indoline derivatives and their use as 5-HT2 receptor ligands
08/29/2007CN100333785C Preparation method for eliminating thrombus and promoting lactation
08/29/2007CN100333769C Chinese herbal granule for treating viral myocarditis and its preparing process
08/29/2007CN100333746C Method for preparing Chinese medicine preparation for treating chronic conjestive heart-failure
08/29/2007CN100333743C Hemorrhoid treating medicine
08/29/2007CN100333729C Breviscapine permeation pump control release preparation
08/29/2007CN100333722C Stable oil-in-water emulsion of propyl gallate for vein and its preparing method
08/28/2007US7262309 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1
08/28/2007US7262302 Antiinflammatory action; rheumatoid arthritis
08/28/2007US7262277 Antagonistic anti-hFAS ligand human antibodies and fragments thereof
08/28/2007US7262221 Hydrophobic core coupled to plurality of hydrophilic moieties that form micelles in solution; encapsulate lipoproteins; atherosclerosis; cardiovascular disorders
08/28/2007US7262218 Polymorphic forms are suitable for use as active substances of pharmaceutical dosage forms for reduction of serum cholesterol levels in the bloodstream
08/28/2007US7262203 For therapy of hyperproliferative diseases such as cancer or retinopathy; pazopanib and salts
08/28/2007US7262201 Quinazoline derivatives
08/28/2007US7262192 Such as 1-(2-ethoxyethyl)-3-methyl-5-[(3R)-3-methylpiperazin-1-yl]-N-pyrimidin-4-yl-1H-pyrazolo[4,3-d]pyrimidin-7-amine; cyclic-guanosine monophosphate phosphodiesterase inhibitors
08/28/2007US7262187 Substituted oxazolo- and thizaolopyrimidinones as a mitotic kinesin inhibitor
08/28/2007US7262184 Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
08/28/2007US7261896 Methods for preventing strokes by inducing tolerance to e-selectin
08/28/2007CA2579758A1 Epimers and isomers of tetrazole containing rapamycin analogs, methods of making and using the same
08/28/2007CA2579735A1 Isomers of rapamycin and 42-epi-rapamycin, methods of making and using the same
08/28/2007CA2579734A1 Isomers and 42-epimers of rapamycin alkyl ether analogs, methods of making and using the same
08/28/2007CA2461157C Sustained release heterodisperse hydrogel systems - amorphous drugs
08/28/2007CA2294515C Eprosartan monohydrate
08/28/2007CA2125763C P40 homodimer of interleukin-12
08/23/2007WO2007095424A1 Novel tricyclic dihydropyrazines as potassium channel openers
08/23/2007WO2007094513A2 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension
08/23/2007WO2007094462A1 Non-human animal having modified genome or offspring thereof
08/23/2007WO2007094404A1 Process for production of optically active carboxylic acid compound
08/23/2007WO2007094342A1 Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function
08/23/2007WO2007094340A1 Vasodilator
08/23/2007WO2007094027A2 Methods for the diagnosis of proliferative and/or conformational diseases
08/23/2007WO2007094026A1 Prophylactic and/or therapeutic treatment of proliferative and conformational diseases
08/23/2007WO2007093608A1 Drug combinations for the treatment of respiratory tract diseases
08/23/2007WO2007093183A2 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases
08/23/2007WO2007071839A3 Potentiation of apoptosis by monoclonal antibodies
08/23/2007WO2007053415A3 Agents for the treatment of cardiac arrhythmias
08/23/2007WO2007047205A8 Enzyme inhibitors of pai-1
08/23/2007WO2006093276A8 Pluripotent stem cell derived from cardiac tissue
08/23/2007WO2002097035A3 Secreted proteins
08/23/2007US20070197829 Process for the synthesis and crystalline form agomelatine
08/23/2007US20070197821 Process for the preparation of high purity perindopril
08/23/2007US20070197659 Antagonist of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
08/23/2007US20070197644 Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
08/23/2007US20070197633 Novel forms of pravastatin sodium
08/23/2007US20070197602 Combined pharmaceutical composition
08/23/2007US20070197582 Imidazo[[1, 5-a] pyridine derivatives and methods for treating aldosterone mediated diseases
1 ... 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 ... 1595